Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity.

This publication has 22 references indexed in Scilit:

• Cytokine Induction and Therapeutic Synergy with Interleukin-2 Against Murine Renal and Colon Cancers by Xanthenone-4-Acetic Acid Derivatives
  Journal of Immunotherapy, 1992
• Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.
  The Journal of Experimental Medicine, 1991
• Induction of natural killer activity by Xanthenone analogues of flavone acetic acid: Relation with antitumour activity
  European Journal of Cancer and Clinical Oncology, 1991
• Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids
  Journal of Medicinal Chemistry, 1991
• Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid
  European Journal of Cancer and Clinical Oncology, 1990
• ROLE OF TUMOR-NECROSIS-FACTOR IN FLAVONE ACETIC ACID-INDUCED TUMOR VASCULATURE SHUTDOWN
  1990
• Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.
  The Journal of Experimental Medicine, 1990
• Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality
  Life Sciences, 1989
• Blood Flow Failure as a Major Determinant in the Antitumor Action of Flavone Acetic Acid
  JNCI Journal of the National Cancer Institute, 1989
• Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo
  Journal of Medicinal Chemistry, 1989